Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.
Substituted boronic acids and boronate esters as immunoproteasome inhibitors
申请人:MERCK PATENT GMBH
公开号:US10294246B2
公开(公告)日:2019-05-21
Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.